Market Place
Sourcing Support
ITM to Present at Oppenheimer’s 35th Annual Healthcare Conference
07 Feb 2025 //
GLOBENEWSWIRE
ITM P 3 Compete Trial Shows Positive ITM-11 Data In GEP-NETs Tumors
28 Jan 2025 //
GLOBENEWSWIRE
ITM, Ariceum Ink Deal For Actinium-225 Radioisotope Supply
13 Jan 2025 //
GLOBENEWSWIRE
ITM To Present At J.P. Morgan Healthcare Conference
13 Dec 2024 //
GLOBENEWSWIRE
ITM to Participate in Upcoming Investor Conferences
11 Nov 2024 //
GLOBENEWSWIRE
ITM And TUM Sign Agreement For Radiopharmaceutical Treatments
24 Oct 2024 //
GLOBENEWSWIRE
ITM, NTP Renew Agreement To Strengthen Radioisotope Production
18 Oct 2024 //
GLOBENEWSWIRE
ITM Raises €188M For Radiopharma Pipeline, Radioisotope Manufacturing
06 Jun 2024 //
GLOBENEWSWIRE
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
07 May 2024 //
GLOBENEWSWIRE
ITM, Helmholtz, Münster Dose First Glioblastoma Patient in Phase 1 Trial
23 Apr 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.